Rheumatoid arthritis decisions — 2025

The Veteran's appeal for service connection for an overactive immune system, rheumatoid arthritis, and hepatitis B was withdrawn by the Veteran's representative.

The Board remands the issue of entitlement to service connection for rheumatoid arthritis for additional development, including obtaining a medical opinion from a physician regarding whether the Veteran's RA was caused or aggravated by his service-connected disabilities.

The Board remands the claims for service connection for an acquired psychiatric disorder, rheumatoid arthritis, heart disease, and bladder cancer, as well as additional compensation benefits for the Veteran's spouse, due to a need for further medical evidence.

The Board remands the claims for anemia, joint disability, and anal cancer to obtain additional evidence.

The Veteran was granted a 60 percent rating for residuals of lung cancer, status post right lobectomy and a TDIU effective May 28, 2019.

The Board denied service connection for rheumatoid arthritis, finding no current diagnosis and no evidence of the condition during or related to active service.

The appeal for service connection for rheumatoid arthritis was dismissed due to a procedural defect in the filing of the appeal, and the claim for service connection for a right shoulder disability was denied based on insufficient evidence of a current disability.

The veteran's claims for service connection for rheumatoid arthritis, double hip replacement, and an acquired psychiatric disorder (including PTSD) were denied. The claim for migraines was remanded.

The Board remands the claims for service connection due to an inadequate medical opinion regarding the nature and etiology of the Veteran's conditions.

The veteran's claim for service connection for muscle and joint pain, related to Gulf War service, was granted based on new evidence.

The Board remands the Veteran's claim for service connection for rheumatoid arthritis to obtain an addendum medical opinion addressing potential in-service exposures, including silica dust and tuberculosis.

The Board remanded the veteran's claims for service connection for rheumatoid arthritis (gout), headaches, hypertension, and obstructive sleep apnea. The Board found that the VA did not adequately assist the veteran in obtaining necessary medical examinations or opinions.

The veteran's claim for diabetes mellitus, type II was dismissed. All other claims were remanded for further development.

The Board granted readjudication for several conditions due to new and relevant evidence. Some claims were denied, and others were remanded for further review.

The Board has remanded the claims for further development due to inconsistencies in previous opinions and need for an assessment without considering the ameliorative effects of pain medication.

The Board has remanded the cases for further development and consideration due to new evidence added since the last supplemental statement of the case.

The Board has remanded the issues of increased ratings for IVDS and radiculopathy, as well as service connection for diabetes mellitus. The Veteran's disability remains at a 40 percent rating from May 28, 2024.

The Board remanded the Veteran's claims for service connection for chronic cough, chronic respiratory infections, sleep apnea, and rheumatoid arthritis. The Board found that VA did not obtain necessary medical examinations or records to support these claims.

The Board remanded the claim to correct errors in assisting the veteran, including investigating chemical exposures and obtaining medical records.

The Board remanded the claim for arthritis, including rheumatoid arthritis, osteoarthritis, and gout, for further development. The Veteran's service in Vietnam is acknowledged, and exposure to herbicide agents like TCDD is conceded.